Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹10 Cr
Revenue (TTM)
₹7 Cr
Net Profit (TTM)
₹1 Cr
ROE
61 %
ROCE
83.2 %
P/E Ratio
16.4
P/B Ratio
6.1
Industry P/E
41.94
EV/EBITDA
11.9
Div. Yield
0 %
Debt to Equity
0
Book Value
₹2.9
EPS
₹1.1
Face value
10
Shares outstanding
5,471,900
CFO
₹0.32 Cr
EBITDA
₹1.11 Cr
Net Profit
₹-4.55 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Nexus Surgical
| 0.0 | 2.2 | 15.8 | 17.7 | 18.0 | 38.0 | -- |
|
BSE Healthcare
| -1.7 | -1.1 | -1.9 | 7.5 | 25.6 | 15.6 | 10.7 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2019
|
|---|---|---|---|---|---|
|
Nexus Surgical
| -33.5 | 144.5 | -15.1 | 463.7 | -59.2 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | -3.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Nexus Surgical
|
17.5 | 9.6 | 7.3 | 0.6 | 10.6 | 47.6 | 16.4 | 6.1 |
| 87.0 | 31.7 | 54.6 | -1.1 | 3.6 | -3.5 | -- | 1.1 | |
| 64.5 | 32.5 | 150.3 | -2.2 | -0.6 | -4.8 | -- | 0.6 | |
| 1,664.8 | 27,406.4 | 6,112.8 | 847.2 | 17.2 | 9.2 | 32.4 | 2.8 | |
| 177.0 | 972.3 | 264.6 | 19.3 | 8.9 | 6.2 | 41.9 | 4.2 | |
| 845.4 | 10,147.0 | 6,537.7 | 207.0 | 4.6 | 11.5 | 49 | 5.3 | |
| 1,279.1 | 12,965.9 | 1,781.6 | 341.3 | 19.8 | 12.4 | 37.3 | 4.3 | |
| 116.4 | 42.8 | 20.6 | 2.5 | 18.7 | 16.9 | 17.2 | 2.6 |
No Review & Analysis are available.
Nexus Commodities and Technologies Limited engages in the wholesale of pharmaceutical and medical goods in India. The company also distributes precious metals, stones, and jewelry. In addition, it provides commodity related sales and advisory... services. The company was incorporated in 1992 and is based in Mumbai, India. Read more
Incorporated
1992
Chairman
--
Managing Director
Ram Swaroop Mahadev Joshi
Headquarters
Palghar, Maharashtra
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View AnnouncementsResults - Financial Results For 31-12-2025
14-Feb-2026Reply On Clarification Sought By Exchange
03-Jan-2026
The share price of Nexus Surgical And Medicare Ltd is ₹17.50 (BSE) as of 18-Mar-2026 IST. Nexus Surgical And Medicare Ltd has given a return of 18.04% in the last 3 years.
The P/E ratio of Nexus Surgical And Medicare Ltd is 16.40 times as on 18-Mar-2026, a 61 discount to its peers’ median range of 41.94 times.
The P/B ratio of Nexus Surgical And Medicare Ltd is 6.14 times as on 18-Mar-2026, a 120 premium to its peers’ median range of 2.79 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
18.14
|
8.48
|
|
2024
|
34.58
|
13.03
|
|
2023
|
27.72
|
13.41
|
|
2022
|
14.22
|
22.64
|
|
2021
|
12.26
|
-17.49
|
The 52-week high and low of Nexus Surgical And Medicare Ltd are Rs 22.00 and Rs 13.26 as of 19-Mar-2026.
Nexus Surgical And Medicare Ltd has a market capitalisation of ₹ 10 Cr as on 18-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Nexus Surgical And Medicare Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹-0.55
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.